IRA INFORM REPORT

 

 

Report No. :

332066

Report Date :

14.07.2015

 

IDENTIFICATION DETAILS

 

Name :

WOCKHARDT LIMITED

 

 

Registered Office :

C-3, G Block, Wockhardt Towers, Bandra Kurla Complex, Bandra East, Mumbai – 400051, Maharashtra

Tel. No.:

91-22-26534444 / 26533333 / 26522727

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

08.07.1999

 

 

Com. Reg. No.:

11-120720

 

 

Capital Investment / Paid-up Capital :

Rs. 3535.900 Million

 

 

CIN No.:

[Company Identification No.]

L24230MH1999PLC120720

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

NSKW00152F

 

 

PAN No.:

[Permanent Account No.]

AAACW2472M

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Subject engaged in the business of Manufacture and Marketing of Pharmaceutical Products.

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (60)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist 

 

 

Comments :

Subject is a well-established company having fine track record.

 

There is drastic tip in the profit of the company during 2015. However, general financial position of the company seems to be sound and healthy.

 

Trade relations are fair. Business is active. Payment terms are reported to be regular and as per commitments.

 

The company can be considered good for business dealings at usual trade terms and conditions.

 

Note: Subject has been found under RBI Defaulter’s list the name of Credit Grantors is Royal Bank of Scotland and the amount charged is Rs. 2607.37 Lacs dated 30-06-2011.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE RATING

Rating

Long Term Bank Facilities = Aa

Rating Explanation

Have high degree of safety and carry very low credit risk

Date

April 20, 2015

 

Rating Agency Name

CARE RATING

Rating

Short Term Bank Facilities = A1+

Rating Explanation

Have very strong degree of safety and carry lowest credit risk

Date

April 20, 2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION DENIED

 

Management non co-operative (91-22-26534444)

 

 

LOCATIONS

 

Registered / Corporate Office :

C-3, G Block, Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai – 400051, Maharashtra, India

Tel. No.:

91-22-26534444 / 26533333 / 26522727

Fax No.:

91-22-26522727 / 26522828 / 26534242

E-Mail :

wock@giasbm01.vsnl.net.in

wockhard@giasbm01.vsnl.net.in

ocassubhoy@wockhardtin.com

spathak@wockhardt.com

contactus@wockhardt.com

jmanmadkar@wockhardt.com

cpatodi@wackhardt.com

Website :

www.wockhardt.com

 

 

Factory 1 :

Wockhardt Biotech Park, H14/2 M.I.D.C., Area Waluj, Aurangabad - 431136, Maharashtra, India

Tel. No.:

91-240-6626444

Fax No.:

91 240 6626333

 

 

Factory 2 :

L1 M.I.D.C., Chikalthana, Aurangabad - 431210, Maharashtra, India

Tel. No.:

91-240-6637444

Fax No.:

91-240-6637333

 

 

Factory 3 :

87A, Silver Industrial Estate, Bhimpore, Nani Daman - 396210, Union Territory, India

Tel. No.:

91-260-6610300 / 6610333

Fax No.:

91-260-2220940

 

 

Factory 4 :

106/4,5,7 Kadaiya, Nani Daman 396210, Union Territory India

Tel. No.:

91260-6531306

Fax No.:

91-260-2220214

 

 

Factory 5 :

138 G.I.D.C. Estate, Ankleshwar 393002, District Bharuch, Gujarat, India

Tel. No.:

91-2646-661444

Fax No.:

91-2646-661555

 

 

Factory 6 :

P O Barotiwala, District Solan, Himachal Pradesh 174103, India

Tel. No.:

91-1795-664444

Fax No.:

91-1795-664242

 

 

Factory 7 :

Ash Raod North, Wexham Industrial Estate, Wrexham, LL13 9UF, Wales, UK

Tel. No.:

+44-1978-661261

Fax No.:

+44-1978-660130

 

 

Factory 8 :

Ballymacarbry Clonmel Co., Tippearary, Ireland

Tel. No.:

+353-52-6186000

Fax No.:

+353-52-6136311

 

 

Factory 9 :

6451, Main Street, Morton Frove, III Inois 60053-2633, USA

Tel. No.:

+1-847+9675600

Fax No.:

+1-847-9672211

 

 

Factory 10 :

B-15/2, MIDC Waluj-431136, Maharashtra, India 

Tel. No.:

91-240-6636400

Fax No.:

91-240-6636444

 

 

International Office :

Located At:

 

  • USA
  • UK
  • Ireland
  • Switzerland

 

 

Research Centers  :

Located At:

 

  • India
  • UK
  • USA

 

 

DIRECTORS

 

As on: 31.03.2014

 

Name :

Dr. Habil Khorakiwala

Designation :

Chairman

 

 

Name :

Dr. Huzaifa Khorakiwala

Designation :

Executive Director

 

 

Name :

Dr. Murtaza Khorakiwala

Designation :

Managing Director

 

 

Name :

Mr. Shekhar Datta

Designation :

Director

 

 

Name :

Mr. Aman Mehta

Designation :

Director

 

 

Name :

Mr. R A Shah

Designation :

Director

 

 

Name :

Mr. D. S. Brar

Designation :

Director

 

 

Name :

Mr. Sanjaya Baru

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. V R Khetan

Designation :

Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 31.03.2015

 

Category of Shareholder

No. of Shares

% of Holdings

(A) Shareholding of Promoter and Promoter Group

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

887625

0.81

http://www.bseindia.com/include/images/clear.gifBodies Corporate

81097757

73.77

http://www.bseindia.com/include/images/clear.gifSub Total

81985382

74.58

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

81985382

74.58

(B) Public Shareholding

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

626783

0.57

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

1438109

1.31

http://www.bseindia.com/include/images/clear.gifInsurance Companies

1400

0.00

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

10624240

9.66

http://www.bseindia.com/include/images/clear.gifSub Total

12690532

11.54

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

1651833

1.50

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

9856265

8.97

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

1079096

0.98

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

2665435

2.42

http://www.bseindia.com/include/images/clear.gifClearing Members

349765

0.32

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

874619

0.80

http://www.bseindia.com/include/images/clear.gifTrusts

6210

0.01

http://www.bseindia.com/include/images/clear.gifDirectors & their Relatives & Friends

57100

0.05

http://www.bseindia.com/include/images/clear.gifForeign Nationals

100

0.00

http://www.bseindia.com/include/images/clear.gifForeign Portfolio Investors

1377641

1.25

http://www.bseindia.com/include/images/clear.gifSub Total

15252629

13.88

Total Public shareholding (B)

27943161

25.42

Total (A)+(B)

109928543

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

144360

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

144360

0.00

Total (A)+(B)+(C)

110072903

0.00

 

 

Shareholding of securities (including shares, warrants, convertible securities) of persons belonging to the category Promoter and Promoter Group

 

Sl.No.

Name of the Shareholder

Details of Shares held

No. of Shares held

As a % of grand total (A)+(B)+(C)

1

Themisto Trustee Company Pvt Ltd

6,58,97,757

59.87

2

Pasithee Trustee Company Pvt Ltd

52,00,000

4.72

3

Ananke Trustee Company Pvt Ltd

50,00,000

4.54

4

Callirhoe Trustee Company Pvt Ltd

50,00,000

4.54

5

Habil F Khorakiwala

4,42,785

0.40

6

Murtaza Habil Khorakiwala

2,26,200

0.21

7

Huzaifa Habil Khorakiwala

2,16,000

0.20

8

Nafisa Habil Khorakiwala

2,640

0.00

 

Total

8,19,85,382

74.48

 

 

Shareholding of securities (including shares, warrants, convertible securities) of persons belonging to the category Public and holding more than 1% of the total number of shares

 

Sl. No.

Name of the Shareholder

No. of Shares held

1

Life Insurance Corporation Of India

1326871

 

Total

1326871

 

 

 Details of Depository Receipts (DRs)

 

Sl. No.

Type of Outstanding DR (ADRs, GDRs, SDRs, etc.)

No. of Outstanding DRs

No. of Shares Underlying 
Outstanding DRs

Shares Underlying Outstanding DRs as % of Total No. of Shares

1

Global Depository Receipts (GDRs)

1,44,360

1,44,360

0.13

 

Total

1,44,360

1,44,360

0.13

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject engaged in the business of Manufacture and Marketing of Pharmaceutical Products

 

 

Products :

Not Divulged

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

Not Divulged

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

  • ICICI Bank
  • State Bank of India

 

 

Facilities :

(Rs. In Million)

(Rs. In Millions)

Secured Loan

As on 31.03.2015

As on

31.03.2014

LONG TERM BORROWINGS

 

 

Rupee Denominated Term Loans from others

NA

9.700

 

 

 

SHORT TERM BORROWINGS

 

 

Working capital facilities from banks

NA

1632.300

 

 

 

Total

NA

1642.000

 

Auditors :

 

Name :

Haribhakti and Company

Chartered Accountants

 

Holding Company :

  • Khorakiwala Holdings and Investments Private Limited

 

Associates :

  • Swiss Biosciences AG

 

Wholly Owned Subsidiaries :

  • Wockhardt UK Holdings Limited (formerly, Wockhardt UK Limited)
  • CP Pharmaceuticals Limited
  • CP Pharma (Schweiz) AG
  • Wallis Group Limited
  • The Wallis Laboratory Limited
  • Wockhardt Farmaceutica Do Brasil Ltda
  • Wallis Licensing Limited
  • Wockhardt Biopharm Limited
  • Vinton Healthcare Limited
  • Wockhardt Infrastructure Development Limited
  • Z and Z Services GmbH (formerly, esparma GmbH)
  • Wockhardt Europe Limited
  • Wockhardt Nigeria Limited
  • Wockhardt USA LLC w.e.f. October 3, 2008 (formerly, Wockhardt USA Inc.,)
  • Wockhardt Bio AG (Formerly Wockhardt EU Operations (Swiss) AG)
  • Wockhardt UK Limited
  • Wockhardt Cyprus Limited
  • Wockpharma Ireland Limited
  • Pinewood Laboratories Limited
  • Pinewood healthcare Limited
  • Nonash Limited
  • Laboratoires Negma S.A.S. (formerly, Negma Lerads S.A.S.)
  • Wockhardt France (Holdings) S.A.S.
  • Esparma AG
  • Wockhardt Holding Corp
  • Morton Grove Pharmaceuticals, Inc.
  • MGP Inc.
  • Girex S.A.S. (liquidated on October 6, 2011)
  • Mazal Pharmaceutique S.A.R.L. (liquidated on October 6, 2011)
  • Laboratoires Pharma 2000 S.A.S. (formerly, Pharma 2000 S.A.S.)
  • Hariphar S.C.
  • Niverpharma S.A.S.
  • Negma Beneulex S.A.
  • S.C.I. Salome
  • Phytex S.A.S.
  • Scomedia S.A.S. (sold on May 16, 2011)
  • Laboratoires Lerads S.A.S. (Merged on November 28, 2012)
  • Wockhardt Farmaceutica SA DE CV. (w.e.f. November 9, 2012)
  • Wockhardt Services SA DE CV. (w.e.f. June 21, 2012)

 

Fellow Subsidiary :

  • Carol Info Services Limited

 

Other Related Parties :

  • Palanpur Holdings and Investments Private Limited
  • Wockhardt Hospitals Limited
  • Merind Limited
  • Wockhardt Foundation
  • Dartmour Holdings Private Limited

 

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2015

 

Authorised Capital : Not Available

 

Issued, Subscribed & Paid-up Capital : Rs. 3535.900 Million

 

As on: 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000000

Equity Shares

Rs.5/- each

Rs. 1250.000 Millions

2000000000

Preference Shares

Rs.5/- each

Rs. 10000.000 Millions

 

TOTAL

 

Rs. 11250.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

109435903

Equity Shares

Rs.5/- each

Rs. 547.200 Millions

167750

Add : Shares Issued during the year Pursuant to ESOS

 

Rs. 0.900 Million

121454927

Optionally Convertible Cumulative Redeemable Preference Shares

Rs.5/- each

Rs. 607.200 Millions

475659941

Non-Convertible Cumulative Redeemable Preference Shares

Rs.5/- each

Rs. 2378.300 Millions

 

 

 

 

 

TOTAL

 

Rs. 3534.300 Millions

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

3535.900

3534.300

3533.400

(b) Reserves & Surplus

10165.000

8821.300

7633.800

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

13700.900

12355.600

11167.200

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

5677.300

70.000

95.200

(b) Deferred tax liabilities (Net)

1316.000

1367.000

1205.500

(c) Other long term liabilities

0.000

6286.300

0.000

(d) long-term provisions

334.800

280.500

260.800

Total Non-current Liabilities (3)

7328.100

8003.800

1561.500

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

2701.700

1744.400

1631.700

(b) Trade payables

3444.000

3306.900

4693.000

(c) Other current liabilities

14048.100

8231.800

11746.500

(d) Short-term provisions

266.500

271.100

873.300

Total Current Liabilities (4)

20460.300

13554.200

18944.500

 

 

 

 

TOTAL

41489.300

33913.600

31673.200

 

 

 

 

ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

17976.500

9943.600

8768.600

(ii) Intangible Assets

0.000

385.200

597.600

(iii) Capital work-in-progress

0.000

5818.300

4817.900

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

2972.200

3079.500

3079.500

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term Loan and Advances

3777.700

3723.200

3429.200

(e) Other Non-current assets

1037.100

1061.900

49.200

Total Non-Current Assets

25763.500

24011.700

20742.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

5244.300

4844.600

5275.900

(c) Trade receivables

2097.000

2463.600

2066.300

(d) Cash and cash equivalents

6784.900

857.900

1839.300

(e) Short-term loans and advances

1599.600

1735.800

1749.700

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

15725.800

9901.900

10931.200

 

 

 

 

TOTAL

41489.300

33913.600

31673.200

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

44815.400

18052.700

24711.800

 

 

Other Income

(511.500)

3193.800

455.000

 

 

TOTAL                                     (A)

44303.900

21246.500

25166.800

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

7839.800

5133.100

8593.000

 

 

Purchases of Stock-in-Trade

7545.100

2809.600

2614.300

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(510.100)

47.100

3010.700

 

 

Employees benefits expense

8688.700

3545.300

5609.700

 

 

96332

0.000

406.400

(2881.800)

 

 

Other expenses

12980.900

5857.500

(829.500)

 

 

TOTAL                                     (B)

36544.400

17799.000

(198.400)

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

7759.500

3447.500

25365.200

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

552.100

336.700

1543.700

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

7207.400

3110.800

23821.500

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

1454.000

963.200

807.700

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

5753.400

2147.600

23013.800

 

 

 

 

 

Less

TAX                                                                  (H)

1626.500

161.500

(829.800)

 

 

 

 

 

 

Profit for the year from Continuing Operations

0.000

0.000

6067.600

 

 

 

 

 

 

Profit for the discontinued operations (before

tax)

0.000

0.000

236.000

 

 

 

 

 

 

Tax expenses of discounted operations

0.000

0.000

(76.600)

 

 

 

 

 

 

Profit from discontinued operations

0.000

0.000

159.400

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX

4126.900

1986.100

6227.000

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Exports of goods on F.O.B. basis

 

 

11740.400

 

 

Management and Technical fees

 

 

57.800

 

 

Out licensing fees

 

 

1677.700

 

 

Royalty

 

 

31.100

 

 

Interest

 

 

34.800

 

 

Research and Development Services

 

 

40.600

 

 

Assignment of New Chemical Entity

 

 

1000.000

 

 

Others

 

 

0.000

 

TOTAL EARNINGS

NA

11025.600

14582.400

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

 

 

2538.200

 

 

Component and Spares

 

 

44.900

 

 

Capital Goods

 

 

260.200

 

TOTAL IMPORTS

NA

3760.100

2843.300

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

36.81

18.10

56.88

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.3.2014

31.03.2013

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

1612.190

1866.520

Net cash flow from (used in) operating activities

NA

1476.290

1532.400

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

9.21

4.32

30.47

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

17.31

19.10

36.62

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.94

3.76

28.18

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.42

0.08

0.60

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.61

0.15

0.15

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.77

0.73

0.58

 

 

STOCK PRICES

 

Face Value

Rs. 5.00/-

Market Value

Rs. 1498.90/-

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

3533.400

3534.300

3535.900

Reserves & Surplus

7633.800

8821.300

10165.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

11167.200

12355.600

13700.900

 

 

 

 

long-term borrowings

95.200

70.000

5677.300

Short term borrowings

1631.700

1744.400

2701.700

Current Maturities of Long Term Debt

0.000

0.000

0.000

Total borrowings

1726.900

1814.400

8379.000

Debt/Equity ratio

0.155

0.147

0.612

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

24711.800

18052.700

44815.400

 

 

(26.947)

148.248

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

24711.800

18052.700

44815.400

Profit

7528.800

779.200

4126.900

 

30.47%

4.32%

9.21%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

-----

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

No

10

Date of Birth of Proprietor / Partners / Directors

No

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

-----

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

-----

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

----

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

UNSECURED LOAN

(Rs. In Millions)

Particulars

As on 31.03.2015

As on

31.03.2014

LONG TERM BORROWINGS

 

 

Sales tax deferral loan

NA

21.200

Loans from Others

NA

39.100

 

 

 

SHORT TERM BORROWINGS

 

 

Buyers’ credit

NA

112.100

 

 

 

Total

NA

172.400

 

 

LITIGATION DETAILS:

 

Case Details

 

Bench:-Bombay

 

Lodging No.:-

NMSL/197/2014

Filing Date:-

29.01.2014

 

Main Matter

 

Lodging No.:-

Sl/3957/998

Reg No.:-

S/4077/1998

 

 

Petitioner :

CAUVERY SOFTWARE ENGG. SYSTEMS LIMITED

Respondent:-

WOCKHARDT LIMITED AND ORS.

Petn. Adv.:

RAHUL SHANKAR ARPOTE (I2585)

 

 

 

District:- MUMBAI

 

Bench:- DIVISION    

                                 

Status:- Pre-Admission                                                  Category:- NOTICE OF MOTION

 

Last Date : 05/02/2014

 

Last Coram: ACCORDING TO SITTING LIST 

 

Act : Code of civil procedure 1908

 

 

INDEX OF CHARGE:

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10253301

07/12/2011 *

26,152,000.00

DEPARTMENT OF BIOTECHNOLOGY

6-8th FLOOR, BLOCK NO. 2,, CGO COMPLEX, LODHI ROA 
D, NEW DELHI, Delhi - 110003, INDIA

B27629591

2

10239938

15/03/2011 *

16,412,700,000.00

SBICAP TRUSTEE COMPANY LIMITED

202, MAKER TOWER, 'E', CUFFE PARADE,, COLABA,, MU 
MBAI, Maharashtra - 400005, INDIA

B09941931

3

10240003

31/08/2010

16,932,800,000.00

SBICAP TRUSTEE COMPANY LIMITED

202, MAKER TOWER, 'E', CUFFE PARADE,, COLABA,, MU 
MBAI, Maharashtra - 400005, INDIA

A94607587

4

10238614

18/08/2010

29,864,500,000.00

STATE BANK OF INDIA

CAPITAL MARKET BRANCH, VIDEOCON HERITAGE, GROUND 
FLOOR, CHARANJIT RAI MARG, MUMBAI, Maharashtra - 4 
00001, INDIA

A92103076

5

10225953

29/06/2010

4,667,210,000.00

SBICAP TRUSTEE COMPANY LIMITED

202, MAKER TOWER, 'E', CUFFE PARADE,, COLABA,, MU 
MBAI, Maharashtra - 400005, INDIA

A88114897

6

10195016

23/11/2009

484,900,000.00

HDFC BANK LIMITED

HDFC BANK HOUSESENAPATI BAPAT MARG, LOWER PAREL W 
, MUMBAI, Maharashtra - 400013, INDIA

A76885995

7

10192780

23/11/2009

2,990,100,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, Gujarat - 390015,

INDIA

A75404855

8

10199434

23/11/2009

3,820,000,000.00

STATE BANK OF INDIA

CORPORATE ACCOUNTS GROUP BRANCH,, VOLTAS HOSE, 23 
, J.N. HEREDIA MARG, MUMBAI, Maharashtra - 400001, 
INDIA

A76706431

9

10038845

08/02/2007

11,250,000,000.00

STATE BANK OF INDIA

NEW ISSUE AND SECURITIES AND SERVICES DIVSIONS,, 
MUMBAI MAIN BRANCH, MUMBAI SAMACHAR MARG,, MUMBAI, 
Maharashtra - 400023, INDIA

A11304755

10

90144213

21/04/2009 *

4,725,000,000.00

STATE BANK OF INDIA

Corporate Accounts Group branch, Voltas House, 23 
, J.N Heredia Marg, Voltas House, Ballard Estate, 
Mumbai, Maharashtra - 400001, INDIA

A63782932

 

* Date of charge modification

 

 

FIXED ASSETS:

 

  • Trademarks / Technical knowhow
  • Software
  • Freehold land
  • Leasehold land

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 63.37

UK Pound

1

Rs. 97.65

Euro

1

Rs. 70.43

 

 

INFORMATION DETAILS

 

Information Gathered by :

SPR

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

JYO

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

YES

--EPF

YES/NO

NO

TOTAL

 

60

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.